DBV Technologies | DBVT - Ordinary Share Capital

Stock Price
21.14
Daily Change
-0.32 -1.49%
Monthly
-2.45%
Yearly
381.00%
Q1 Forecast
20.91

DBV Technologies reported $11.65M in Ordinary Share Capital for its fiscal quarter ending in March of 2025.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 168.71M 104K Sep/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Amarin USD 20.8M 28K Sep/2025
BioCryst Pharmaceuticals USD 1.9M 3K Sep/2023
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
DBV Technologies USD 11.65M 1000 Mar/2025
Esperion Therapeutics USD 112K 11K Sep/2023
Galectin Therapeutics USD 61K 0 Dec/2023
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Insmed USD 214.26M 1.67M Dec/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
Neurocrine Biosciences USD 100.1M 400K Dec/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Sarepta Therapeutics USD 104.77M 7.06M Sep/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
United Therapeutics USD 42.9M 42.1M Sep/2025